2018 First Half results press release

Download our press release published on 26 July to find out the financial results for the first half 2018.


No votes yet
 
Relacionados
ROVI reports operating revenue growth of 8% and net profit growth of 83%
Laboratorios Farmacéuticos Rovi, S.A. (BME: ROVI), compañía farmacéutica paneuropea especializada y dedicada a la investigación,...
11 min
27/07/2020
ROVI and Moderna Announce Collaboration for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate
Moderna, Inc. (Nasdaq: MRNA), compañía biotecnológica de estadio clínico pionera en terapias y vacunas de ARN mensajero (ARNm) para crear...
3 min
09/07/2020